The recent study by McMaster University researchers, which found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally, will only increase physician and patient confusion over efficacy of HRT, as it fails to make the all-important distinction between the types of HRT used by women in the group with higher incidence of breast cancer. 

A study to be published in Jan 2012 Journal of Epidemiology and Community Health by McMaster University researchers have found consistent evidence that use of hormone replacement therapy (HRT) is associated with breast cancer globally.  This study comes at a time when more women are seeking HRT medication from the doctors to control the symptoms of menopause, such as hot flashes, weight gain and mood swings.

THURSDAY, June 16 (HealthDay News) -- The use of hormone replacement therapy (HRT) appears to help protect postmenopausal women against the development of peripheral artery disease, new research indicates.

The risk reduction for peripheral artery disease, or PAD, was found even though the group of women on HRT were more likely to have conditions such as high cholesterol and high blood pressure, the researchers reported.

WASHINGTON (EGMN) – A small but important percentage of postmenopausal women not taking hormone replacement therapy have an endometrial lining that is suspicious for polyps, according to a prospective study of 1,500 consecutive asymptomatic women.